Hepatitis C Virus (HCV) Market Size & Share Analysis Hepatitis C Virus is a viral infection that causes liver inflammation, sometimes leading to serious liver damage. It is caused by the hepatitis C virus (HCV) and is a major cause of liver cancer.The total prevalent cases of Hepatitis C Virus in the 7MM was 8,257,162 in 2017. The prevalent cases of HCV in the US was 3,251,471. As per the Delveinsight, the therapeutic market of Hepatitis C Virus in the 7MM was found to be USD 10,445 million in 2017, which is expected to increase during the forecast period. The key companies in the Hepatitis C Virus market include Cocrystal Pharma, Atea Pharmaceuticals, PRISM Pharma, Ohara Pharmaceuticals, GeneCure Biotechnologies, and others. Source: https://www.delveinsight.com/report-store/hepatitis-c-virus-market



